JP2018509460A5 - - Google Patents

Download PDF

Info

Publication number
JP2018509460A5
JP2018509460A5 JP2017550556A JP2017550556A JP2018509460A5 JP 2018509460 A5 JP2018509460 A5 JP 2018509460A5 JP 2017550556 A JP2017550556 A JP 2017550556A JP 2017550556 A JP2017550556 A JP 2017550556A JP 2018509460 A5 JP2018509460 A5 JP 2018509460A5
Authority
JP
Japan
Prior art keywords
syndrome
disease
hypochlorous acid
acid composition
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017550556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018509460A (ja
Filing date
Publication date
Priority claimed from US14/670,641 external-priority patent/US9999635B2/en
Application filed filed Critical
Priority claimed from PCT/US2016/024453 external-priority patent/WO2016160668A1/en
Publication of JP2018509460A publication Critical patent/JP2018509460A/ja
Publication of JP2018509460A5 publication Critical patent/JP2018509460A5/ja
Pending legal-status Critical Current

Links

JP2017550556A 2015-03-27 2016-03-28 炎症疾患及び免疫疾患を治療するための方法及び組成物 Pending JP2018509460A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/670,641 2015-03-27
US14/670,641 US9999635B2 (en) 2007-01-16 2015-03-27 Methods and compositions for treating inflammatory disorders
PCT/US2016/024453 WO2016160668A1 (en) 2015-03-27 2016-03-28 Methods and compositions for treating inflammatory and immunological disorders

Publications (2)

Publication Number Publication Date
JP2018509460A JP2018509460A (ja) 2018-04-05
JP2018509460A5 true JP2018509460A5 (https=) 2019-05-09

Family

ID=57006380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017550556A Pending JP2018509460A (ja) 2015-03-27 2016-03-28 炎症疾患及び免疫疾患を治療するための方法及び組成物

Country Status (12)

Country Link
US (2) US10617716B2 (https=)
EP (1) EP3273973A4 (https=)
JP (1) JP2018509460A (https=)
KR (1) KR20180012745A (https=)
CN (1) CN107847520A (https=)
AU (1) AU2016243554A1 (https=)
CA (1) CA2980966A1 (https=)
HK (1) HK1250337A1 (https=)
IL (1) IL254671A0 (https=)
MX (1) MX2017012433A (https=)
SG (1) SG11201707892YA (https=)
WO (1) WO2016160668A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
EP3233091A4 (en) 2014-12-16 2018-07-18 Realm Therapeutics, Inc. Hypochlorous acid formulations and methods for treating skin conditions
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
ZA201707084B (en) * 2016-10-21 2018-11-28 Ultrapure Hocl Pty Ltd Hypochlorous acid
WO2018230743A1 (ja) * 2017-06-17 2018-12-20 株式会社エースネット ラジカル発生触媒、ラジカルの製造方法、酸化反応生成物の製造方法、薬剤および農畜産用薬剤
KR20210005936A (ko) * 2018-05-02 2021-01-15 오큐소프트, 인코포레이티드 차아염소산 기반 눈꺼풀 세정제
CN112703005A (zh) * 2018-07-17 2021-04-23 费灵有限公司 包括微生物群恢复治疗（mrt）组合物的联合疗法
EP3993811B1 (en) * 2019-07-03 2025-02-26 Apr Applied Pharma Research S.A. Therapeutic uses of oxidising hypotonic acid solutions
JP2021171322A (ja) * 2020-04-24 2021-11-01 ニプロ株式会社 次亜塩素酸の呼吸器への導入システム
WO2021235506A1 (ja) * 2020-05-21 2021-11-25 国立大学法人大阪大学 上皮癌治療薬
US20220079981A1 (en) * 2020-09-15 2022-03-17 Facerestoration Ltd Lavage techniques and virucidal compositions comprising hypochlorous solutions
US20220202853A1 (en) * 2020-12-28 2022-06-30 Briotech, Inc. Hypohalous acids for treating inflammatory diseases and inhibiting growth of malignancies
GB202110146D0 (en) * 2021-07-14 2021-08-25 Hypo Stream Ltd Treatment of respiratory conditions
WO2024183061A1 (zh) * 2023-03-09 2024-09-12 英属维京群岛商白因子国际股份有限公司台湾分公司 一种次氯酸组合物用于制备预防、改善或治疗放射性皮肤炎的医药组合物的用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10236961A (ja) * 1997-02-25 1998-09-08 Nobel Igaku Kenkyusho:Kk 電解酸性水を用いた眼科用剤
JP2000063279A (ja) * 1998-08-07 2000-02-29 Medical Discoveries Inc 新規免疫機能向上剤
GB2355190B (en) 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
US20030185704A1 (en) * 2000-01-12 2003-10-02 Suzanne Bernard Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
US9168318B2 (en) * 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
CA2602522C (en) * 2005-03-23 2014-09-09 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
EP1959972A4 (en) * 2005-12-13 2009-06-03 Puricore Inc PROCESS FOR TREATING OPEN INJURIES BY HYPOCHLOROUS ACID
EP1993571B1 (en) * 2006-01-20 2018-07-25 Sonoma Pharmaceuticals, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
CN101405013A (zh) 2006-01-20 2009-04-08 奥古露丝创新科学公司 使用氧化还原电位水溶液治疗或预防腹膜炎的方法
CA2650973A1 (en) 2006-05-03 2007-11-08 University Of Manitoba Microbial markers of inflammatory bowel disease
JP4372121B2 (ja) * 2006-06-24 2009-11-25 有限会社上川製作所 家畜腸内の大腸菌減少剤、家畜体内の脂肪減少剤及び家畜の飼育方法
US9999635B2 (en) 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
WO2008089268A2 (en) 2007-01-16 2008-07-24 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
US20100266710A1 (en) * 2007-07-26 2010-10-21 Mihran Baronian Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
KR101715631B1 (ko) 2008-04-01 2017-03-13 안티포딘 파마슈티칼스, 인코포레이티드 피부 관리를 위한 조성물 및 방법
JP2011116730A (ja) * 2009-12-04 2011-06-16 Yasuharu Shima 呼吸器系疾患の予防と治療方法
US20120251831A1 (en) * 2009-12-16 2012-10-04 Japan Carlit Co., Ltd Near-infrared absorptive coloring matter and near-infrared absorptive composition
MX390111B (es) 2011-03-18 2025-03-19 Urgo Us Inc Soluciones estabilizadas de acido hipohaloso.
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions

Similar Documents

Publication Publication Date Title
JP2018509460A5 (https=)
Emad et al. Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation
Kanikowska et al. Influence of chlorinated water on the development of allergic diseases-An overview
Dixit et al. Effects of threshold inspiratory muscle training versus conventional physiotherapy on the weaning period of mechanically ventilated patients: a comparative study
JP2009501202A5 (https=)
Maierean et al. Complementary therapeutic approaches in asthma
Rodríguez et al. Effects of home-based respiratory muscle training in children and adolescents with chronic lung disease
CN117222355A (zh) 帕金森病的治疗
Nabavi et al. Prevalence of mold allergy in patients with allergic rhinitis referred to Semnan clinic of allergy
Bednarek Overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea
Burman et al. FACILITATING HUFF FOR AIRWAY CLEARANCE AND TO RELIEVE DYSPNEA IN SUBJECTS WITH COPD
WO2012040767A1 (en) Method of treating disorders using magnesium
Strechen et al. Theoretical substantiation and practical application of local therapy of respiratory diseases in children
Puech et al. Solriamfetol Improves Chronic Sleep Fragmentation-Induced Adverse Effects on Novel Object Recognition in Mice
Boukari et al. Membrane Progestrone receptors α and β contribute to regulation of breathing in adult male and female mice
Op De Beeck et al. Characteristics of upper airway collapse assessed during drug-induced sleep endoscopy predict response and deterioration under mandibular advancement device therapy
Ross et al. A 50-year old woman with nasal congestion, cough, and dyspnea
Balcerek et al. Asthma in athletes and the use of asthma treatment
Van de Perck et al. The Value of Awake Nasopharyngoscopy with Müller’s Maneuver in the Prediction of Response to Mandibular Advancement Device Treatment
Ajepe et al. Cough Effectiveness, Functional Independence and Quality of Life of Stroke Survivors: A Cross-sectional Survey
Yamamoto et al. Investigating the Optimal Assistive Strategy for Freezing of Gait: A Comparison of Unilateral and Bilateral Artificial Muscle Assistance
Tayade et al. Goal-oriented rehabilitation in a 15-year-old case of cystic bronchiectasis secondary to Pierre-robin sequence-Case report
Harmon The Reactive Relationship Between the Gut Microbiome and The Brian Health
AndreevÐ et al. Asthma and dental health in children. Review of the literature
Nakata et al. Early And Late Onset Adverse Events In LAM Patients Treated With Sirolimus For Two Years